3. Asai Y, Tan J, Baibergenova A, Barankin B, Cochrane CL, Humphrey S, et al. Canadian clinical practice guidelines for rosacea. J Cutan Med Surg 2016 Sep 1;20(5):432-45.10.1177/1203475416650427
6. Two AM, Wu W, Gallo RL, Hata TR. Rosacea: Part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015 May 1;72(5):749-58.10.1016/j.jaad.2014.08.02825890455
7. Ozbagcivan O, Ozturk T, Akarsu S, Ilknur T, Fetil E. Evaluation of metabolic syndrome and its components in patients with rosacea: A cross-sectional, case-control study. Hong Kong J Dermatol. 2020;28(2):55-62.
10. Chen Q, Shi X, Tang Y, Wang B, Xie H fu, Shi W, et al. Association between rosacea and cardiometabolic disease: A systematic review and meta-analysis. J Am Acad Dermatol. 2020 Nov 1;83(5):1331-40.10.1016/j.jaad.2020.04.11332360724
12. Forton FMN. The Pathogenic Role of Demodex Mites in Rosacea: A Potential Therapeutic Target Already in Erythematotelangiectatic Rosacea? Vol. 10, Dermatology and Therapy. Adis; 2020:1229-53.10.1007/s13555-020-00458-9764919033095403
16. Forton FMN, de Maertelaer V. Two consecutive standardized skin surface biopsies: An improved sampling method to evaluate demodex density as a diagnostic tool for rosacea and demodicosis. Acta Derm Venereol. 2017;97(2):242-8.10.2340/00015555-252827573185
17. Forton FMN, de Maertelaer V. Treatment of rosacea and demodicosis with benzyl benzoate: effects of different doses on Demodex density and clinical symptoms. J Eur Acad Dermatol Venereol. 2019; 34(2):365-9.
18. Forton FMN, de Maertelaer V. Papulopustular rosacea and rosacea-like demodicosis: two phenotypes of the same disease? J Eur Acad Dermatol Venereol. 2018 Jun 1;32(6):1011-6.10.1111/jdv.14885600180829478301
19. Forton F, Germaux MA, Brasseur T, de Liever A, Laporte M, Mathys C, et al. Demodicosis and rosacea: Epidemiology and significance in daily dermatologic practice. J J Am Acad Dermatol. 2005;52(1):74-87.10.1016/j.jaad.2004.05.03415627084
20. Tas Cengiz Z, Ozkol HU, Beyhan YE, Ozturk M, Yilmaz H. Evaluation of some chronical diseases in etiopathogenesis of demodicosis. Dermatologica Sin. 2017;35(4):173-6.10.1016/j.dsi.2017.04.006
21. Belli AA, Gok SO, Akbaba G, Etgu F, Dogan G. The relationship between rosacea and insulin resistance and metabolic syndrome. Eur J Dermatol. 2016;26(3):260-4.10.1684/ejd.2016.274827328660
23. Tucker LA. Limited Agreement between Classifications of Diabetes and Prediabetes Resulting from the OGTT, Hemoglobin A1c, and Fasting Glucose Tests in 7412 U.S. Adults. J Clin Med. 2020;9(7):1-18.10.3390/jcm9072207740866732668564
24. Sánchez-García A, Rodríguez-Gutiérrez R, Mancillas-Adame L, González-Nava V, Díaz González-Colmenero A, Solis RC, et al. Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review. Int J Endocrinol. 2020;2020:1-7.10.1155/2020/4678526708584532256572
25. Altemani A, Alamri A, Ahmed M, al Garbo M, Alharbi T, Al-Rasheed R, et al. Prediabetes and serum insulin levels. Int JComm Med Pub H. 2018;5(5):1684-9.10.18203/2394-6040.ijcmph20181494
27. Lacey N, Ní Raghallaigh S, Powell FC. Demodex mites - Commensals, parasites or mutualistic organisms?, Dermatol. 2011;22(2): 128-30.10.1159/00032300921228556
28. Lacey N, Russell-Hallinan A, Powell FC. Study of Demodex mites: Challenges and Solutions. J Eur Acad Dermatol Venereol. 2016;30(5):764-75.10.1111/jdv.1351726695086
29. Friedman P, Cohen Sabban E, Cabo H. Usefulness of dermoscopy in the diagnosis and monitoring treatment of demodicidosis. Dermatol Pract Concept. 2017;7(1):35-8.10.5826/dpc.0701a06531503828243492
31. García-Vargas A, Mayorga-Rodríguez JA, Sandoval-Tress C. Scalp demodicidosis mimicking favus in a 6-year-old boy. J Am Acad Dermatol. 2007;57(2):19-21.10.1016/j.jaad.2006.04.08217637363
32. Fernandez-Flores A, Alija A. Scalp folliculitis with Demodex: Innocent observer or pathogen? Vol. 13, Braz J Infect Dis. 2009. p. 81-2.10.1590/S1413-8670200900020000120140347
34. Chuprov AD, Malgina EK. Modern aspects of etiopathogenetic treatment of ophthalmodemodicosis (literature review). Oftalmologiya.2018;15:281-5.10.18008/1816-5095-2018-2S-281-285
35. Huang Y, He H, Sheha H, Tseng SCG. Ocular demodicosis as a risk factor of pterygium recurrence. Ophthalmol. 2013;120(7):1341-7.10.1016/j.ophtha.2013.01.00123664471
40. Álvarez-Salafranca M, Vicente A, Prat Torres C, Combalia A, Monsonís M, Celis-Passini VP, et al. Demodicosis in two patients with a previous history of Langerhans cell histiocytosis. Pediatr Dermatol. 2017;34(6):299-301.10.1111/pde.1328628940244
41. Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal. 2017;38(32):2459-71.10.1093/eurheartj/ehx144583722528444290
43. Li Y, Guo L, Hao D, Li X, Wang Y, Jiang X. Association between Rosacea and Cardiovascular Diseases and Related Risk Factors: A Systematic Review and Meta-Analysis. Biomed Res Int. 2020;2020:1-11.10.1155/2020/7015249732028532685519
44. Katsambas A, Dessinioti C. The changing faces of acne, rosacea, and hidradenitis suppurativa. Clin Dermatol. 2017;35 (2):114-7.10.1016/j.clindermatol.2016.10.00228274347
46. Tang Q, Li X, Song P, Xu L. Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: Developments in research and prospects for the future. Drug Discov Ther. 2015;9(6):380-5.10.5582/ddt.2015.0120726781921
47. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International. Circulation. 2009;120(16):1640-5.10.1161/CIRCULATIONAHA.109.19264419805654
48. Brož J, Malinovská J, Nunes MA, Kučera K, Rožeková K, Žejglicová K, et al. Prevalence of diabetes and prediabetes and its risk factors in adults aged 25–64 in the Czech Republic: A cross-sectional study. Diabetes Res Clin Pract 2020; 170:108470.10.1016/j.diabres.2020.10847032998019
49. Chen YH, Lee YC, Tsao YC, Lu MC, Chuang HH, Yeh WC, et al. Association between high-fasting insulin levels and metabolic syndrome in non-diabetic middle-aged and elderly populations: A community-based study in Taiwan. BMJ Open. 2018;8(5):1-7.10.1136/bmjopen-2017-016554594246829724734